Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1971 3
1974 1
1978 1
1984 1
1992 1
1996 2
2004 2
2005 2
2006 2
2007 1
2008 2
2009 3
2010 3
2011 4
2012 1
2013 1
2014 2
2015 6
2016 6
2017 4
2018 5
2019 7
2020 7
2021 3
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
A Case of Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation Therapy.
Tamanoi D, Saruwatari K, Imamura K, Sato R, Jodai T, Hamada S, Tomita Y, Saeki S, Ueno S, Yonemura Y, Ichiyasu H, Sakagami T. Tamanoi D, et al. Among authors: saruwatari k. Intern Med. 2021 Nov 13. doi: 10.2169/internalmedicine.7581-21. Online ahead of print. Intern Med. 2021. PMID: 34776479 Free article.
Rapid Integrated Healthcare Response for the First US Evacuees from Wuhan, China, During the COVID-19 Pandemic.
Mesisca M, Leung G, Morris J, Chang M, Verbeck R, Loe S, Cruikshank J, Tabuenca A, Miller R, Kaiser C, Saruwatari K, Pachon A, Randall MM. Mesisca M, et al. Among authors: saruwatari k. Disaster Med Public Health Prep. 2020 Dec 22:1-3. doi: 10.1017/dmp.2020.497. Online ahead of print. Disaster Med Public Health Prep. 2020. PMID: 33720001 Free PMC article.
Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis.
Anai M, Yoshida C, Ozono K, Furukawa H, Ishimaru Y, Sakata S, Saruwatari K, Muramoto K, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Anai M, et al. Among authors: saruwatari k. Allergol Int. 2022 Jan 21:S1323-8930(21)00142-8. doi: 10.1016/j.alit.2021.11.003. Online ahead of print. Allergol Int. 2022. PMID: 35074267 No abstract available.
Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020.
Hallowell BD, Carlson CM, Jacobs JR, Pomeroy M, Steinberg J, Tenforde MW, McDonald E, Foster L, Feldstein LR, Rolfes MA, Haynes A, Abedi GR, Odongo GS, Saruwatari K, Rider EC, Douville G, Bhakta N, Maniatis P, Lindstrom S, Thornburg NJ, Lu X, Whitaker BL, Kamili S, Sakthivel SK, Wang L, Malapati L, Murray JR, Lynch B, Cetron M, Brown C, Roohi S, Rotz L, Borntrager D, Ishii K, Moser K, Rasheed M, Freeman B, Lester S, Corbett KS, Abiona OM, Hutchinson GB, Graham BS, Pesik N, Mahon B, Braden C, Behravesh CB, Stewart R, Knight N, Hall AJ, Killerby ME. Hallowell BD, et al. Among authors: saruwatari k. Emerg Infect Dis. 2020 Sep;26(9):1998-2004. doi: 10.3201/eid2609.201590. Epub 2020 Jul 3. Emerg Infect Dis. 2020. PMID: 32620182 Free PMC article.
Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater.
Jodai T, Saruwatari K, Ikeda T, Moriyama E, Kashiwabara K, Shingu N, Iyonaga K, Inaba M, Ajishi Y, Honda C, Hirosako S, Maruyama H, Kakiuchi Y, Eida H, Tomita Y, Saeki S, Ichiyasu H, Sakagami T. Jodai T, et al. Among authors: saruwatari k. Int J Clin Oncol. 2021 Jan;26(1):78-86. doi: 10.1007/s10147-020-01789-5. Epub 2020 Sep 23. Int J Clin Oncol. 2021. PMID: 32965577
62 results